Journal Article
. 2020 Sep; 9(22):8444-8456.
doi: 10.1002/cam4.3466.

Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis

Lili Huang 1 Hong Chen 2 Yu Xu 3 Jianhua Chen 1 Zhuqing Liu 1 Qing Xu 1 
  • PMID: 32931642
  •     51 References
  •     9 citations


Aims: Different types of tumor-infiltrating immune cells not only augment but also dampen antitumor immunity in the microenvironment of melanoma. Therefore, it is critical to provide an overview of tumor-infiltrating immune cells in melanoma and explore a novel strategy for immunotherapies.

Methods: We analyzed the immune states of different stages in melanoma patients by the immune, stromal, and estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) scores. Immune cell types were identified by the estimating relative subsets of RNA transcripts (CIBERSORTx) algorithm in 471 melanoma and 324 healthy tissues. Moreover, we performed a gene set variation analysis (GSVA) to determine the differentially regulated pathways in the tumor microenvironment.

Results: In melanoma cohorts, we found that ESTIMATE and immune scores were involved in survival or tumor clinical stage. Among the 22 immune cells, CD8+ T cells, M2 macrophages, and regulatory T cells (Tregs) showed significant differences using the CIBERSORTx algorithm. Furthermore, GSVA identified the immune cell-related pathways; the primary immunodeficiency pathway, intestinal immune network for IgA, and TGF-β pathways were identified as participants of the crosstalk in CD8+ T cells, Tregs, and M2 macrophages in the melanoma microenvironment.

Conclusion: These results reveal the cellular and molecular characteristics of immune cells in melanoma, providing a method for selecting targets of immunotherapies and promoting the efficacy of therapies for the treatment of melanoma.

Keywords: CD8+ T cells; M2 macrophage; melanoma; tumor-infiltrating immune cells.

New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.
Irene Gullo, Patrícia Oliveira, +13 authors, Fátima Carneiro.
Gastric Cancer, 2018 May 21; 22(1). PMID: 29779068
Management of melanoma.
Pippa Corrie, Mirela Hategan, Kate Fife, Christine Parkinson.
Br Med Bull, 2014 Sep 06; 111(1). PMID: 25190764
TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells.
Mojgan Ahmadzadeh, Steven A Rosenberg.
J Immunol, 2005 Apr 22; 174(9). PMID: 15843517    Free PMC article.
Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Ann Y Lee, Nicolas Droppelmann, +5 authors, Daniel G Coit.
Ann Surg Oncol, 2016 Nov 03; 24(4). PMID: 27804026    Free PMC article.
GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney.
BMC Bioinformatics, 2013 Jan 18; 14. PMID: 23323831    Free PMC article.
Highly Cited.
Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.
Laurent Muller, Masato Mitsuhashi, +2 authors, Theresa L Whiteside.
Sci Rep, 2016 Feb 05; 6. PMID: 26842680    Free PMC article.
Highly Cited.
Role of NK cell subsets in organ-specific murine melanoma metastasis.
Zuhair K Ballas, Claire M Buchta, +2 authors, Michael R Shey.
PLoS One, 2013 Jun 19; 8(6). PMID: 23776508    Free PMC article.
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis.
Christian Barthels, Ana Ogrinc, +12 authors, Thomas Brocker.
Nat Commun, 2017 Mar 10; 8. PMID: 28276457    Free PMC article.
Determining cell type abundance and expression from bulk tissues with digital cytometry.
Aaron M Newman, Chloé B Steen, +9 authors, Ash A Alizadeh.
Nat Biotechnol, 2019 May 08; 37(7). PMID: 31061481    Free PMC article.
Highly Cited.
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
Yu Kato, Kimiyo Tabata, +13 authors, Yasuhiro Funahashi.
PLoS One, 2019 Feb 28; 14(2). PMID: 30811474    Free PMC article.
Highly Cited.
Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6.
Shingo Eikawa, Yoshihiro Ohue, +4 authors, Eiichi Nakayama.
J Immunol, 2010 Nov 05; 185(11). PMID: 21048114
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.
Tamás Rőszer.
Mediators Inflamm, 2015 Jun 20; 2015. PMID: 26089604    Free PMC article.
Highly Cited. Review.
The sva package for removing batch effects and other unwanted variation in high-throughput experiments.
Jeffrey T Leek, W Evan Johnson, +2 authors, John D Storey.
Bioinformatics, 2012 Jan 20; 28(6). PMID: 22257669    Free PMC article.
Highly Cited.
Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.
Marilyn Giordano, Coralie Henin, +10 authors, Grégory Verdeil.
EMBO J, 2015 Jul 04; 34(15). PMID: 26139534    Free PMC article.
Adjuvant systemic therapy in high-risk melanoma.
Stephanie A Blankenstein, Alexander C J van Akkooi.
Melanoma Res, 2019 Mar 22; 29(4). PMID: 30896556
CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.
Julie Leignadier, Stephanie Favre, Sanjiv A Luther, Immanuel F Luescher.
Oncoimmunology, 2016 May 04; 5(3). PMID: 27141342    Free PMC article.
Tregs in infection and vaccinology: heroes or traitors?
Luciana Berod, Franz Puttur, Jochen Huehn, Tim Sparwasser.
Microb Biotechnol, 2011 Sep 29; 5(2). PMID: 21951341    Free PMC article.
Human macrophage polarization in vitro: maturation and activation methods compared.
Daphne Y S Vogel, Judith E Glim, +5 authors, Robert H J Beelen.
Immunobiology, 2014 Jun 12; 219(9). PMID: 24916404
Highly Cited.
Current controversies in early-stage melanoma: Questions on management and surveillance.
Marki E Klapperich, Glen M Bowen, Douglas Grossman.
J Am Acad Dermatol, 2018 Dec 17; 80(1). PMID: 30553299
Molecular signatures database (MSigDB) 3.0.
Arthur Liberzon, Aravind Subramanian, +3 authors, Jill P Mesirov.
Bioinformatics, 2011 May 07; 27(12). PMID: 21546393    Free PMC article.
Highly Cited.
Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ.
Chang Liu, Maria Chikina, +13 authors, Dario A A Vignali.
Immunity, 2019 Jul 28; 51(2). PMID: 31350177    Free PMC article.
Highly Cited.
Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
K J Busam, C R Antonescu, +4 authors, M Berwick.
Am J Clin Pathol, 2001 Jun 08; 115(6). PMID: 11392882
Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, +6 authors, Ash A Alizadeh.
Nat Methods, 2015 Mar 31; 12(5). PMID: 25822800    Free PMC article.
Highly Cited.
Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, +25 authors, Paolo A Ascierto.
N Engl J Med, 2014 Nov 18; 372(4). PMID: 25399552
Highly Cited.
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
Elisa Peranzoni, Jean Lemoine, +12 authors, Emmanuel Donnadieu.
Proc Natl Acad Sci U S A, 2018 Apr 11; 115(17). PMID: 29632196    Free PMC article.
Highly Cited.
limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, +4 authors, Gordon K Smyth.
Nucleic Acids Res, 2015 Jan 22; 43(7). PMID: 25605792    Free PMC article.
Highly Cited.
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages.
Emmanuel L Gautier, Tal Shay, +15 authors, Immunological Genome Consortium.
Nat Immunol, 2012 Oct 02; 13(11). PMID: 23023392    Free PMC article.
Highly Cited.
Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries.
Claire M Lanier, Ryan Hughes, +14 authors, Michael D Chan.
Neurooncol Pract, 2019 Sep 27; 6(5). PMID: 31555455    Free PMC article.
Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Wenjie Yin, Laurent Gorvel, +13 authors, SangKon Oh.
EBioMedicine, 2016 Apr 15; 5. PMID: 27077111    Free PMC article.
Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma.
Marguerite Mrad, Caroline Imbert, +10 authors, Nathalie Andrieu-Abadie.
Oncotarget, 2016 Oct 07; 7(44). PMID: 27708249    Free PMC article.
The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education.
Nicole Marquardt, Martin A Ivarsson, +7 authors, Jakob Michaëlsson.
J Immunol, 2015 Aug 19; 195(7). PMID: 26283480
An Overview of the Changing Landscape of Treatment for Advanced Melanoma.
Chung-Shien Lee, Christan M Thomas, Kimberly E Ng.
Pharmacotherapy, 2017 Jan 05; 37(3). PMID: 28052356
Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
Lili Huang, Hong Chen, +3 authors, Qing Xu.
Cancer Med, 2020 Sep 16; 9(22). PMID: 32931642    Free PMC article.
Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation.
Muly Tham, Kar Wai Tan, +8 authors, Jean-Pierre Abastado.
Oncotarget, 2014 Oct 09; 5(23). PMID: 25294815    Free PMC article.
The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Satu Salmi, Hanna Siiskonen, +5 authors, Sanna Pasonen-Seppänen.
Melanoma Res, 2018 Nov 07; 29(3). PMID: 30399061    Free PMC article.
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.
Frederick J Kohlhapp, Joseph R Broucek, +16 authors, Howard L Kaufman.
J Immunother Cancer, 2015 May 21; 3. PMID: 25992289    Free PMC article.
The biology of human natural killer-cell subsets.
M A Cooper, T A Fehniger, M A Caligiuri.
Trends Immunol, 2001 Nov 08; 22(11). PMID: 11698225
Highly Cited. Review.
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
Manisha Singh, Christina Vianden, +15 authors, Willem W Overwijk.
Nat Commun, 2017 Nov 14; 8(1). PMID: 29129918    Free PMC article.
DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth.
Jin-Sung Chung, Kyoichi Tamura, Ponciano D Cruz, Kiyoshi Ariizumi.
J Invest Dermatol, 2014 Jun 18; 134(11). PMID: 24936834    Free PMC article.
Computational deconvolution: extracting cell type-specific information from heterogeneous samples.
Shai S Shen-Orr, Renaud Gaujoux.
Curr Opin Immunol, 2013 Oct 24; 25(5). PMID: 24148234    Free PMC article.
Highly Cited. Review.
Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma.
Ryosuke Hino, Kenji Kabashima, +5 authors, Yoshiki Tokura.
Cancer, 2010 Feb 10; 116(7). PMID: 20143437
Highly Cited.
Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity.
Dapeng Hao, Jie Liu, +5 authors, Li-Jun Di.
Clin Cancer Res, 2018 Apr 18; 24(15). PMID: 29661778
Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.
Nicola Mozzillo, Corrado Caracò, +5 authors, Paolo Antonio Ascierto.
World J Surg Oncol, 2013 Feb 06; 11. PMID: 23379355    Free PMC article.
CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection.
Qiang Zou, Bing Wu, +5 authors, Bin Wang.
Eur J Immunol, 2013 Oct 12; 44(1). PMID: 24114149    Free PMC article.
The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Franca Piras, Romano Colombari, +6 authors, Paola Sirigu.
Cancer, 2005 Aug 04; 104(6). PMID: 16078259
Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
Laureen S Ojalvo, Elizabeth D Thompson, +5 authors, Leisha A Emens.
Hum Pathol, 2017 Dec 31; 74. PMID: 29288043
Inferring tumour purity and stromal and immune cell admixture from expression data.
Kosuke Yoshihara, Maria Shahmoradgoli, +12 authors, Roel G W Verhaak.
Nat Commun, 2013 Oct 12; 4. PMID: 24113773    Free PMC article.
Highly Cited.
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer.
Marco Greppi, Giovanna Tabellini, +7 authors, Emanuela Marcenaro.
Int J Mol Sci, 2019 Feb 23; 20(4). PMID: 30791364    Free PMC article.
Functions of natural killer cells.
Eric Vivier, Elena Tomasello, +2 authors, Sophie Ugolini.
Nat Immunol, 2008 Apr 22; 9(5). PMID: 18425107
Highly Cited. Review.
Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study.
Rong Liu, Rong Hu, +2 authors, Hong-Hao Zhou.
EBioMedicine, 2020 Jan 09; 51. PMID: 31911269    Free PMC article.
Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.
Angeles Domínguez-Soto, Elena Sierra-Filardi, +5 authors, Angel L Corbí.
J Immunol, 2011 Jan 18; 186(4). PMID: 21239715
Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
Lili Huang, Hong Chen, +3 authors, Qing Xu.
Cancer Med, 2020 Sep 16; 9(22). PMID: 32931642    Free PMC article.
Immune classification of osteosarcoma.
Trang Le, Sumeyye Su, Leili Shahriyari.
Math Biosci Eng, 2021 Mar 25; 18(2). PMID: 33757216    Free PMC article.
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
Jinfang Liu, Zijian Zhou, +6 authors, Gang Yao.
Cancer Cell Int, 2021 Aug 28; 21(1). PMID: 34446007    Free PMC article.
Microdissection of the Bulk Transcriptome at Single-Cell Resolution Reveals Clinical Significance and Myeloid Cells Heterogeneity in Lung Adenocarcinoma.
Hao Wu, Jiale Qin, +2 authors, Chen Li.
Front Immunol, 2021 Oct 19; 12. PMID: 34659209    Free PMC article.
Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients.
Zhehong Li, Junqiang Wei, +4 authors, Yu Jin.
Medicine (Baltimore), 2022 Jan 15; 101(1). PMID: 35029920    Free PMC article.
Screening of Autophagy-Related Prognostic Genes in Metastatic Skin Melanoma.
Cao-Jie Chen, Hiroki Kajita, +2 authors, Kazuo Kishi.
Dis Markers, 2022 Jan 25; 2022. PMID: 35069935    Free PMC article.
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients.
Chi Yan, Sheau-Chiann Chen, +5 authors, Ann Richmond.
NPJ Precis Oncol, 2022 Jan 22; 6(1). PMID: 35058553    Free PMC article.
Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
Bharati Mehani, Saleembhasha Asanigari, +4 authors, Kenneth Aldape.
Acta Neuropathol Commun, 2022 Feb 12; 10(1). PMID: 35144680    Free PMC article.
High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
Guochao Mao, Changyou Shan, +3 authors, Shuqun Zhang.
Int J Gen Med, 2022 Mar 15; 15. PMID: 35282644    Free PMC article.